- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2017-09-01
2028-04-30
2030-04-30
500
NCT03260842
Stanford University
Stanford University
OBSERVATIONAL
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.
Observational study to collect bio-specimens from 2 separate patient cohorts identified to be at high risk for subsequent development of pancreas cancer. 1. Patients diagnosed with a pancreatic cyst undergoing either endoscopic ultrasound or surgery. Bio-specimens collected include pancreatic cyst fluid and blood. These will be collected using a standard operating protocol. 2. Patients defined as a high risk individual for pancreas cancer by family history and/or known genetic mutations. Bio-specimens collected include blood. This will be collected using a standard operating protocol.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2017-08-22 | N/A | 2025-03-26 |
2017-08-22 | N/A | 2025-04-01 |
2017-08-24 | N/A | 2025-03 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Pancreatic Cysts Patients with pancreatic cyst undergoing endoscopic ultrasound and/or surgery who will have bio-specimens collected | DIAGNOSTIC_TEST: Bio-Specimen Collection
|
| : High Risk Individuals Patients with established family history and/or genetic mutations for Pancreas cancer who will have bio-specimens collected | DIAGNOSTIC_TEST: Bio-Specimen Collection
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Pancreas Cancer | Development of Pancreas Cancer | 5-10 years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
|
Study Contact Name: Walter Park, MD Phone Number: 650-723-4102 Email: wgpark@stanford.edu |
Study Contact Backup Name: Sharon Pneh Phone Number: 650-724-1336 Email: spneh@stanford.edu |
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
